Advisory Research’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,417
| Closed | -$297K | – | 381 |
|
|
2018
Q3 | $297K | Sell |
2,417
-1,124
| -32% | -$138K | ﹤0.01% | 344 |
|
|
2018
Q2 | $348K | Sell |
3,541
-2,041
| -37% | -$201K | 0.01% | 336 |
|
|
2018
Q1 | $463K | Sell |
5,582
-1,585
| -22% | -$131K | 0.01% | 315 |
|
|
2017
Q4 | $556K | Sell |
7,167
-7,808
| -52% | -$606K | 0.01% | 321 |
|
|
2017
Q3 | $918K | Sell |
14,975
-4,830
| -24% | -$296K | 0.01% | 318 |
|
|
2017
Q2 | $911K | Sell |
19,805
-1,963
| -9% | -$90.3K | 0.01% | 322 |
|
|
2017
Q1 | $943K | Sell |
21,768
-22,112
| -50% | -$958K | 0.01% | 323 |
|
|
2016
Q4 | $1.7M | Buy |
+43,880
| New | +$1.7M | 0.03% | 227 |
|